Charles LeVea
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Co-authors
- Mark I. Greene (2 shared papers)Xiaolan Qian (3 shared papers)William C. Dougall (3 shared papers)Takuro Wada (2 shared papers)Jeffrey N. Myers (2 shared papers)Valerie I. Brown (2 shared papers)Renuka Iyer (17 shared papers)Kunio Dobashi (1 shared paper)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Proceedings of the National Academy of Sciences (2 papers)Oncology (2 papers)Journal of Surgical Research (2 papers)
- Partner nations
- United StatesTürkiye
In The Last Decade
Charles LeVea
69 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 97
- Oncology 828
- Radiology, Nuclear Medicine and Imaging 295
- Immunology and Allergy 69
- Immunology 225
- Cancer Research 140
Countries citing papers authored by Charles LeVea
This map shows the geographic impact of Charles LeVea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles LeVea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles LeVea more than expected).
Fields of papers citing papers by Charles LeVea
This network shows the impact of papers produced by Charles LeVea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles LeVea. The network helps show where Charles LeVea may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles LeVea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 281 | |
| 2 | 1994 | 138 | |
| 3 | 2007 | 138 | |
| 4 | 2007 | 91 | |
| 5 | 2016 | 86 | |
| 6 | 1994 | 83 | |
| 7 | 2009 | 65 | |
| 8 | 1998 | 54 | |
| 9 | 2014 | 54 | |
| 10 | 2007 | 49 | |
| 11 | 2007 | 40 | |
| 12 | 2018 | 39 | |
| 13 | 2013 | 37 | |
| 14 | 2014 | 32 | |
| 15 | 2013 | 32 | |
| 16 | Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins. | 1990 | 31 |
| 17 | 2008 | 29 | |
| 18 | 2000 | 29 | |
| 19 | 2007 | 27 | |
| 20 | 2002 | 27 |
About Charles LeVea
Charles LeVea is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 71 papers that have together received 1.8k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (10 papers), Pancreatic and Hepatic Oncology Research (6 papers), Gastric Cancer Management and Outcomes (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Cancer Research and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Oncology (828 citations), Radiology, Nuclear Medicine and Imaging (295 citations), Immunology and Allergy (69 citations), Immunology (225 citations) and Cancer Research (140 citations). Charles LeVea has collaborated with scholars based in United States and Türkiye. Frequent co-authors include Mark I. Greene, Xiaolan Qian, William C. Dougall, Takuro Wada, Jeffrey N. Myers, Valerie I. Brown, Renuka Iyer, Kunio Dobashi, James G. Davis and Yasuo Kokai. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Oncology and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.